https://www.selleckchem.com/pr....oducts/trastuzumab-d
We found that in 10.1% of the participants the gender index was not in line with participants' **** 12.5% of men and 8.4% of women showed a discrepancy between gender index and ****. Feminine gender characteristics are associated with increased common somatic symptoms and chronic diseases, especially in men. Female **** is associated with a higher common somatic symptom burden, but not with a higher prevalence of chronic diseases. The study shows that gender and **** uniquely impact health, and should be considered in epidemi